Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis

Abstract

Adipokines are secreted from adipose tissue, influence energy homeostasis and may contribute to the association between obesity and hypertension. Among 1897 participants enrolled in the Multi-Ethnic Study of Atherosclerosis, we examined associations between blood pressure and leptin, tumor necrosis factor-α (TNFα), resistin and total adiponectin. The mean age and body mass index (BMI) was 64.7 years and 28.1, respectively, and 50% were female. After adjustment for risk factors, a 1-s.d.-increment higher leptin level was significantly associated with higher systolic (5.0 mm Hg), diastolic (1.9), mean arterial (2.8) and pulse pressures (3.6), as well as a 34% higher odds for being hypertensive (P<0.01 for all). These associations were not materially different when the other adipokines, as well as BMI, waist circumference or waist-to-hip ratio, were additionally added to the model. Notably, the associations between leptin and hypertension were stronger in men, but were not different by race/ethnic group, BMI or smoking status. Adiponectin, resistin and TNFα were not independently associated with blood pressure or hypertension. Higher serum leptin, but not adiponectin, resistin or TNFα, is associated with higher levels of all measures of blood pressure, as well as a higher odds of hypertension, independent of risk factors, anthropometric measures and other selected adipokines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ogden CL, Carroll MD, Kit BK, Flegal KM . Prevalence of Obesity in the United States, 2009–2010. National Center for Health Statistics: Hyattsville, MD, 2012.

    Google Scholar 

  2. Grundy SM . Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89 (6): 2595–2600.

    Article  CAS  PubMed  Google Scholar 

  3. Leong KS, Wilding JP . Obesity and diabetes. Best PracRes Clin Endocrinol 1999; 13 (2): 221–237.

    Article  CAS  Google Scholar 

  4. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP . Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. JHypertens 1994; 12 (12): 1433–1437.

    Article  CAS  Google Scholar 

  5. Jones DW . Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens 1996; 9 (8): 50s–54s.

    Article  CAS  PubMed  Google Scholar 

  6. Wofford MR, Hall JE . Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10 (29): 3621–3637.

    Article  CAS  PubMed  Google Scholar 

  7. Rahmouni K, Correia ML, Haynes WG, Mark AL . Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45 (1): 9–14.

    Article  CAS  PubMed  Google Scholar 

  8. Montani JP, Antic V, Yang Z, Dulloo A . Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S28–S38.

    Article  CAS  PubMed  Google Scholar 

  9. Landsberg L, Krieger DR . Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2 (3 Pt 2): 125S–132S.

    Article  CAS  PubMed  Google Scholar 

  10. Hall JE, Louis K . Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23 (3): 381–394.

    Article  CAS  PubMed  Google Scholar 

  11. Ouchi N, Parker JL, Lugus JJ, Walsh K . Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Meier U, Gressner AM . Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50 (9): 1511–1525.

    Article  CAS  PubMed  Google Scholar 

  13. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156 (9): 871–881.

    Article  PubMed  Google Scholar 

  14. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M et al. Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30 (11): 2289–2296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18 (6): 499–502.

    CAS  PubMed  Google Scholar 

  16. McClelland RLKR, Haessler J, Blumenthal RS, Goff DC . Estimation of risk factor associations when the response is influenced by medication use: an imputation approach. Stat Med 2008; 27 (24): 5039–5053.

    Article  PubMed  Google Scholar 

  17. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR . Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24 (19): 2911–2935.

    Article  PubMed  Google Scholar 

  18. Lilja M, Rolandsson O, Shaw JE, Pauvaday V, Cameron AJ, Tuomilehto J et al. Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. Int J Obes (Lond) 2010; 34 (5): 878–885.

    Article  CAS  Google Scholar 

  19. Hall JE, Hildebrandt DA, Kuo J . Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14 (6 Pt 2): S103–S115.

    Article  Google Scholar 

  20. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334 (5): 292–295.

    Article  CAS  PubMed  Google Scholar 

  21. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI . Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100 (2): 270–278.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Beltowski J . Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24 (5): 789–801.

    Article  CAS  PubMed  Google Scholar 

  23. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG . Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20 (8): 1633–1641.

    Article  CAS  PubMed  Google Scholar 

  24. Hausberg M, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG . Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptor-mediated effect. Diabetes 2002; 51 (8): 2434–2440.

    Article  CAS  PubMed  Google Scholar 

  25. Beltowski J, Wojcicka G, Borkowska E . Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 2002; 10 (9): 939–946.

    Article  CAS  PubMed  Google Scholar 

  26. Beltowski J, Wj G, Gorny D, Marciniak A . Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat—impaired effect in dietary-induced obesity. Med Sci Monit 2002; 8 (6): BR221–BR229.

    CAS  PubMed  Google Scholar 

  27. Villarreal D, Reams G, Freeman RH, Taraben A . Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol 1998; 275 (6 Pt 2): R2056–R2060.

    CAS  PubMed  Google Scholar 

  28. Shek EW, Brands MW, Hall JE . Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31 (1 Pt 2): 409–414.

    Article  CAS  PubMed  Google Scholar 

  29. Kuo JJ, Jones OB, Hall JE . Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 2001; 37 (2 Part 2): 670–676.

    Article  CAS  PubMed  Google Scholar 

  30. Dobrian AD, Schriver SD, Lynch T, Prewitt RL . Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am J Physiol Renal Physiol 2003; 285 (4): F619–F628.

    Article  CAS  PubMed  Google Scholar 

  31. Asferg C, Mogelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL et al. Leptin, not adiponectin, predicts hypertension in the copenhagen city heart study. Am J Hypertens 2009; 23 (3): 327–333.

    Article  PubMed  Google Scholar 

  32. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11 (1): 160–166.

    Article  PubMed  Google Scholar 

  33. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10 (10 Pt 1): 1171–1174.

    Article  CAS  PubMed  Google Scholar 

  34. Ozata M, Ozdemir IC, Licinio J . Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84 (10): 3686–3695.

    Article  CAS  PubMed  Google Scholar 

  35. Atabek ME, Kurtoglu S, Demir F, Baykara M . Relation of serum leptin and insulin-like growth factor-1 levels to intima-media thickness and functions of common carotid artery in children and adolescents with type 1 diabetes. Acta Paediatr 2004; 93 (8): 1052–1057.

    Article  CAS  PubMed  Google Scholar 

  36. Lilja M, Rolandsson O, Norberg M, Soderberg S . The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord 2012; 10 (2): 143–151.

    Article  CAS  PubMed  Google Scholar 

  37. Reseland JE, Anderssen SA, Solvoll K, Hjermann I, Urdal P, Holme I et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001; 73 (2): 240–245.

    Article  CAS  PubMed  Google Scholar 

  38. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M . Sedentary behavior and adiposity-associated inflammation the multi-ethnic study of atherosclerosis. Am J Prev Med 2012; 42 (1): 8–13.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was supported by a grant (R01-HL-088451) and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute. We thank the other investigators, the staff and the participants of the MESA study for their valuable contributions. A full list of investigators and institutions participating in MESA can be found at http://www.mesa-nhlbi.org.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M A Allison.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allison, M., Ix, J., Morgan, C. et al. Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis. J Hum Hypertens 27, 617–622 (2013). https://doi.org/10.1038/jhh.2013.24

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2013.24

Keywords

This article is cited by

Search

Quick links